eISSN: 2084-9869
ISSN: 1233-9687
Polish Journal of Pathology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
3/2019
vol. 70
 
Share:
Share:
more
 
 
abstract:
Original paper

The prognostic significance of CD63 expressionin patients with non-small cell lung cancer

Hyun Min Koh
1
,
Hyo Jung An
1
,
Jae Jun Jung
2
,
Dae Hyun Song
1, 3, 4

1.
Department of Pathology, Gyeongsang National University Changwon Hospital, South Korea
2.
Department of Thoracic and Cardiovascular Surgery, Gyeongsang National University Changwon Hospital, South Korea
3.
Gyeongsang National University School of Medicine, South Korea
4.
Gyeongsang Institute of Health Science, South Korea
Pol J Pathol 2019; 70 (3): 183-188
Online publish date: 2019/12/08
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
CD63 has been suggested to participate in tumorigenesis, invasion, and metastasis. In this study, we aimed to investigate the prognostic significance of CD63 expression in non-small cell lung cancer (NSCLC).

CD63 expression was evaluated in 133 cases of NSCLC via immunohistochemical staining using tissue microarray blocks. We assessed the relationship between CD63 expression and clinicopathological characteristics, as well as the prognostic significance of CD63 expression in NSCLC.

CD63 expression was significantly correlated with patient gender (p < 0.001), smoking history (p = 0.020), histologic type (p < 0.001), tumour stage (p = 0.016), lymph node metastasis (p = 0.034), and TNM stage (p = 0.007). A multivariate Cox proportional hazards regression analysis determined low CD63 expression to be an independent factor for unfavourable disease-free survival (DFS) (HR = 2.043, 95% CI: 1.035-4.035, p = 0.040), and Kaplan-Meier analysis indicated that the low CD63 expression group showed significantly lower DFS than the high CD63 expression group of patients with NSCLC (p = 0.019).

Low CD63 expression might be an unfavourable prognostic factor in patients with NSCLC.
keywords:

carcinoma, CD63, lung, non-small cell, prognosis

Quick links
© 2020 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe